George Budwell

George Budwell


George Budwell has been writing about healthcare and biotechnology companies at the Motley Fool since 2013. His primary interests are novel small molecule drugs, next generation vaccines, and cell therapies.

Recent articles

3 Top Cannabis Stocks to Watch in August

Canopy Growth, Charlotte's Web Holdings, and HEXO Corp. are worth checking out this month. Here's why.

2 Top Stocks to Buy in August

Adverum Biotechnologies and Catalyst Pharmaceuticals could both post sizable gains next month.